Evidence map›Paper›PMID 34291032›Full record

ArticleFrontiers in public health2021

Using Proper Mean Generation Intervals in Modeling of COVID-19.

Xiujuan Tang, Salihu S Musa, Shi Zhao, Shujiang Mei, Daihai He

Abstract read
In one paragraph

Article in Frontiers in public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Reduction in the infection fatality rate of Omicron variant compared with previous variants in South Africa.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  7. Article
  8. Article
  9. COVID-19 contact tracing in Belgium: main indicators and performance, January - September 2021.Archives of public health = Archives belges de sante publique · 2022
    Article
  10. Article
  11. Modelling of Waning of Immunity and Reinfection Induced Antibody Boosting of SARS-CoV-2 in Manaus, Brazil.International journal of environmental research and public health · 2022
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiujuan TangShenzhen Center for Disease Control and Prevention, Shenzhen, China.
Salihu S MusaDepartment of Applied Mathematics, The Hong Kong Polytechnic University, Hong Kong, China.
Shi ZhaoThe Jockey Club School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong, China.
Shujiang MeiShenzhen Center for Disease Control and Prevention, Shenzhen, China.
Daihai HeDepartment of Applied Mathematics, The Hong Kong Polytechnic University, Hong Kong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In susceptible-exposed-infectious-recovered (SEIR) epidemic models, with the exponentially distributed duration of exposed/infectious statuses, the mean generation interval (GI, time lag between infections of a primary case and its secondary case) equals the mean latent period (LP) plus the mean infectious period (IP). It was widely reported that the GI for COVID-19 is as short as 5 days. However, many works in top journals used longer LP or IP with the sum (i.e., GI), e.g., >7 days. This discrepancy will lead to overestimated basic reproductive number and exaggerated expectation of infection attack rate (AR) and control efficacy. We argue that it is important to use suitable epidemiological parameter values for proper estimation/prediction. Furthermore, we propose an epidemic model to assess the transmission dynamics of COVID-19 for Belgium, Israel, and the United Arab Emirates (UAE). We estimated a time-varying reproductive number [

Indexed as

COVID-19BelgiumHumansIsraelSARS-CoV-2United Arab EmiratesCOVID-19generation intervalinfectious periodlatent periodreproduction number

Identifiers

PMID34291032
PMCPMC8287506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.